These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2416158)
1. Relative efficiency of human Langerhans' cells and blood derived dendritic cells as antigen-presenting cells. Bjercke S; Braathen L; Gaudernack G; Thorsby E Acta Derm Venereol; 1985; 65(5):374-8. PubMed ID: 2416158 [TBL] [Abstract][Full Text] [Related]
2. Antigen processing and presentation by epidermal Langerhans cells. Induction of immunity or unresponsiveness. Cruz PD; Bergstresser PR Dermatol Clin; 1990 Oct; 8(4):633-47. PubMed ID: 1979019 [TBL] [Abstract][Full Text] [Related]
3. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network. Bodey B; Bodey B; Kaiser HE In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303 [TBL] [Abstract][Full Text] [Related]
4. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. Geppert TD; Lipsky PE J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267 [TBL] [Abstract][Full Text] [Related]
5. Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells. Meunier L; Gonzalez-Ramos A; Cooper KD J Immunol; 1993 Oct; 151(8):4067-80. PubMed ID: 8409386 [TBL] [Abstract][Full Text] [Related]
6. The role of human epidermal Langerhans cells in skin immunity. Braathen LR Derm Beruf Umwelt; 1987; 35(2):58-61. PubMed ID: 2439270 [TBL] [Abstract][Full Text] [Related]
7. Human rheumatoid synovial and normal blood dendritic cells as antigen presenting cell--comparison with autologous monocytes. Waalen K; Førre O; Teigland J; Natvig JB Clin Exp Immunol; 1987 Oct; 70(1):1-9. PubMed ID: 2826055 [TBL] [Abstract][Full Text] [Related]
8. Involvement of class II HLA molecules in T cell activation by antigen. Implications for the autologous mixed lymphocyte reaction. Thorsby E; Berle E; Scott H; Braathen LR Behring Inst Mitt; 1983 May; (72):129-34. PubMed ID: 6100471 [TBL] [Abstract][Full Text] [Related]
9. Nickel-specific T lymphocyte clones derived from allergic nickel-contact dermatitis lesions in man: heterogeneity based on requirement of dendritic antigen-presenting cell subsets. Kapsenberg ML; Res P; Bos JD; Schootemijer A; Teunissen MB; Van Schooten W Eur J Immunol; 1987 Jun; 17(6):861-5. PubMed ID: 3496226 [TBL] [Abstract][Full Text] [Related]
10. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens. Peeler JS; Niederkorn JY J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767 [TBL] [Abstract][Full Text] [Related]
11. Comparative accessory cell function of human peripheral blood dendritic cells and monocytes. Thomas R; Davis LS; Lipsky PE J Immunol; 1993 Dec; 151(12):6840-52. PubMed ID: 8258694 [TBL] [Abstract][Full Text] [Related]
12. In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells. Moulon C; Péguet-Navarro J; Courtellemont P; Redziniak G; Schmitt D Immunology; 1993 Nov; 80(3):373-9. PubMed ID: 7507088 [TBL] [Abstract][Full Text] [Related]
13. Enhanced antigen-presenting capacity of cultured Langerhans' cells is associated with markedly increased expression of Ia antigen. Shimada S; Caughman SW; Sharrow SO; Stephany D; Katz SI J Immunol; 1987 Oct; 139(8):2551-5. PubMed ID: 3498764 [TBL] [Abstract][Full Text] [Related]
14. Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells. Yan M; Peng J; Jabbar IA; Liu X; Filgueira L; Frazer IH; Thomas R Virology; 2004 Jul; 324(2):297-310. PubMed ID: 15207617 [TBL] [Abstract][Full Text] [Related]
15. [Cutaneous immune system]. Schmitt D C R Seances Soc Biol Fil; 1994; 188(3):207-21. PubMed ID: 7834504 [TBL] [Abstract][Full Text] [Related]
16. Enriched Langerhans cells express more HLA-DR determinants than blood-derived adherent cells (monocytes and dendritic cells). Bjercke S; Gaudernack G; Braathen LR Scand J Immunol; 1985 May; 21(5):489-92. PubMed ID: 2408326 [TBL] [Abstract][Full Text] [Related]
17. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells. Aberer W; Kruisbeek AM; Shimada S; Katz SI J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705 [TBL] [Abstract][Full Text] [Related]
18. Dissection of defective antigen presentation by interferon-gamma-treated fibroblasts. Geppert TD; Lipsky PE J Immunol; 1987 Jan; 138(2):385-92. PubMed ID: 3098840 [TBL] [Abstract][Full Text] [Related]
19. Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes. Peiper M; Goedegebuure PS; Alldinger I; Knoefel WT; Izbicki JR; Eberlein TJ Anticancer Res; 2002; 22(6A):3357-63. PubMed ID: 12530087 [TBL] [Abstract][Full Text] [Related]
20. Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells. Van Tendeloo VF; Snoeck HW; Lardon F; Vanham GL; Nijs G; Lenjou M; Hendriks L; Van Broeckhoven C; Moulijn A; Rodrigus I; Verdonk P; Van Bockstaele DR; Berneman ZN Gene Ther; 1998 May; 5(5):700-7. PubMed ID: 9797876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]